Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, is kicking off NEXT New York 2024, its premier life sciences conference. Uniting more than 1,000 healthcare customers and partners, the event will showcase AI-powered innovations that accelerate clinical trials, streamline data management, and enhance decision-making for life-saving therapies.

At the event, Medidata will unveil three experiences centered on the full ecosystem of clinical trials—data management, patient engagement, and study coordination—providing tools that streamline trial workflows and enhance patient lives. Powered by the world’s largest collection of anonymized and de-identified historical clinical trial data, AI continues to be a foundational element in everything Medidata offers, allowing these experiences to be infused with machine learning and other technologies, such as Medidata Designer and Medidata Rave Lite.

“NEXT New York is our most important event of the year, and we're excited to share new insights and fresh approaches,” said Anthony Costello, CEO, Medidata. “Across two days, we’ll immerse our customers in clinical development, offering insights into our shift from individual products to integrated, patient-centered experiences. We’ll also highlight strategies that simplify trial operations, enhance patient engagement, and prioritize effective data capture and integration from ever more complex sources.”

The conference will feature over 35 customer and partner speeches, from Cogstate, Click Therapeutics, CNS Healthcare, Snowflake, and more, exploring such diverse topics such as AI’s profound impact on clinical research, the extension of longitudinal relationships with patients, and more.

Conference participants will also engage in 28 breakout sessions covering topics that include AI-enabled trial design, central nervous system trials, and more. Additionally, they can join in on three immersive experiences, including the lifecycle of a site from the sponsor's perspective, a data point journey from acquisition to application, and a day-in-the-life of a clinical trial patient. These hands-on demos will provide exclusive insights into Medidata's cutting-edge solutions and site relationships.

To learn more about Medidata NEXT New York, click here, and to register for virtual keynote sessions, click here.

About Medidata

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 34,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,200 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

About Dassault Systèmes

Dassault Systèmes is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all – consumers, patients and citizens. Dassault Systèmes brings value to more than 350,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com.

© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries. All other trademarks are owned by their respective owners. Use of any Dassault Systèmes or its subsidiaries trademarks is subject to their express written approval.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241113854965/en/